Skip to content
Brand AI

RepliCel

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2021

    RepliCel closes first MainPointe investment tranche

    RepliCel announced that it had closed the first tranche of MainPointe Pharmaceuticals' investment, receiving CAD 492,091 in exchange for 729,024 common shares.

    Source